Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-06-11-Speech-2-064"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-06-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Human blood and blood components2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20020611.5.2-064"2
lpv:hasSubsequent	lp_eu:2002-06-11-Speech-2-0652
lpv:speaker	lp:Didier Rod2
lpv:spokenAs	substitute; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 unknown; Les Verts-Europe-Ecologie (1999-07-20--2004-07-19)3 member; G/EFA (1999-07-20--2004-07-19)3 member; Committee on Development and Cooperation (2002-01-17--2004-07-19)3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (2002-02-06--2003-02-28)3
lpv:translated text	"Mr President, I am pleased that Mr Nisticò has included many of our amendments. There are, however, some gaps, requiring amendments to be tabled with a view to ensuring the maximum level of safety of blood products. We therefore consider that all undesirable effects and incidents relating to any stage of the blood donation and transfusion process must be reported, no matter how serious they are. We also consider that it is genuinely essential, in the interests of quality and patient information, for a medical examination to be carried out on all blood donors before blood is taken. Secondly, the question of remuneration for blood donations is fundamental. Most European countries have a system of voluntary, unpaid blood donations. We cannot accept any challenges to this principle, and we believe it should be extended to the whole of the European Union. From an ethical point of view, we cannot defend the idea of selling blood or, indeed, any other component of the body. The human body is not a commodity. In this respect, we find it extremely shocking that companies can make a profit from free blood donations. The remuneration of donations could be counter-productive in terms of quality. Donors motivated by financial gain might be led to deny any health problems they may have, which could have tragic consequences – as in China – for their own health and for the health of recipients. I am not denying the risks in terms of blood supplies, but I think we can motivate potential donors by means other than money. It is in order to ensure that the objectives of this directive, the quality and safety of human blood, are achieved that I am calling on my fellow Members to vote for our amendments."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph